ONCY earnings: next report 2026-08-14, real EPS beat/miss history, analyst consensus Buy, P/E -3.46. Updated 2026-07-23.
Oncolytics Biotech (ONCY) Research Hub
Oncolytics Biotech (ONCY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.7455 USD (-6.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.46, market cap 0.08B. This hub links to the full technical, earnings and options research available for ONCY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7455 USD (-6.23%) |
| 52-week range | 0.7301 USD – 1.08 USD |
| Trend regime | Range |
| 14-day RSI | 38.6 (Bearish) |
| Trailing P/E | -3.46 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-14 |
Available research for ONCY
Covered Call on ONCY: how it works, illustrative setup around the real 0.7455 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ONCY: how it works, illustrative setup around the real 0.7455 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ONCY: how it works, illustrative setup around the real 0.7455 USD price, max profit/loss, breakeven and when to use it. Educational.
ONCY technical analysis: range, last 0.7455 USD, RSI 38.6, 52w range 0.7301 USD–1.08 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ONCY in?
Oncolytics Biotech (ONCY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ONCY in an uptrend or downtrend?
As of 2026-09-11, ONCY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ONCY's trailing P/E ratio?
ONCY's trailing P/E is -3.46, with a market cap of 0.08B. See the earnings research page for full valuation detail.
When does ONCY next report earnings?
ONCY is next scheduled to report earnings on 2026-08-14, with a consensus EPS estimate of -0.07 USD.